A case of NUT (Nuclear protein in testis) midline carcinoma of the ethmoid sinuses

Mioko Matsuo, Toshimitsu Nishijima, Kouji Koike

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

NUT midline carcinomas are rare epithelial malignancies. In 2016, only 48 patients with this tumor involving the head and neck were described, and ours is the second case report from Japan. These tumors are characterized by the presence of thet (15 ; 19) chromosomal translocation, difficulty in pathological diagnosis, young-onset, aggressive nature of the tumor and resistance to standard cancer therapy. We report the case of a 49 -year- old man who was diagnosed as having sinonasal NUT midline carcinoma. He had bone metastasis, and his tumor grew rapidly within a week. The initial diagnosis was Ewing sarcoma, however, the final diagnosis was NUT midline carcinoma with a t (15 ; 19) chromosomal translocation. At least once, a sarcoma-based chemotherapy regimen was effective in reducing the size of the tumor, however, the tumor regrew and became resistant to cisplatin-based chemoradiotherapy and other chemotherapies. The patient died of his disease less than 9 months after the initial diagnosis. For early diagnosis and treatment of NUT midline carcinoma, it is important to have a high index of suspicion for this disease.

Original languageEnglish
Pages (from-to)1337-1342
Number of pages6
JournalJournal of Otolaryngology of Japan
Volume120
Issue number11
DOIs
Publication statusPublished - Jan 1 2017

Fingerprint

Ethmoid Sinus
Nuclear Proteins
Testis
Carcinoma
Neoplasms
Genetic Translocation
Drug Therapy
Ewing's Sarcoma
Chemoradiotherapy
Sarcoma
Cisplatin
Early Diagnosis
Japan
Neck
Head
Neoplasm Metastasis
Bone and Bones

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology

Cite this

A case of NUT (Nuclear protein in testis) midline carcinoma of the ethmoid sinuses. / Matsuo, Mioko; Nishijima, Toshimitsu; Koike, Kouji.

In: Journal of Otolaryngology of Japan, Vol. 120, No. 11, 01.01.2017, p. 1337-1342.

Research output: Contribution to journalArticle

Matsuo, Mioko ; Nishijima, Toshimitsu ; Koike, Kouji. / A case of NUT (Nuclear protein in testis) midline carcinoma of the ethmoid sinuses. In: Journal of Otolaryngology of Japan. 2017 ; Vol. 120, No. 11. pp. 1337-1342.
@article{0097b7e689d442efb638fc854a0e74dc,
title = "A case of NUT (Nuclear protein in testis) midline carcinoma of the ethmoid sinuses",
abstract = "NUT midline carcinomas are rare epithelial malignancies. In 2016, only 48 patients with this tumor involving the head and neck were described, and ours is the second case report from Japan. These tumors are characterized by the presence of thet (15 ; 19) chromosomal translocation, difficulty in pathological diagnosis, young-onset, aggressive nature of the tumor and resistance to standard cancer therapy. We report the case of a 49 -year- old man who was diagnosed as having sinonasal NUT midline carcinoma. He had bone metastasis, and his tumor grew rapidly within a week. The initial diagnosis was Ewing sarcoma, however, the final diagnosis was NUT midline carcinoma with a t (15 ; 19) chromosomal translocation. At least once, a sarcoma-based chemotherapy regimen was effective in reducing the size of the tumor, however, the tumor regrew and became resistant to cisplatin-based chemoradiotherapy and other chemotherapies. The patient died of his disease less than 9 months after the initial diagnosis. For early diagnosis and treatment of NUT midline carcinoma, it is important to have a high index of suspicion for this disease.",
author = "Mioko Matsuo and Toshimitsu Nishijima and Kouji Koike",
year = "2017",
month = "1",
day = "1",
doi = "10.3950/jibiinkoka.120.1337",
language = "English",
volume = "120",
pages = "1337--1342",
journal = "Journal of Otolaryngology of Japan",
issn = "0030-6622",
publisher = "Oto-Rhino-Laryngological Society of Japan Inc.",
number = "11",

}

TY - JOUR

T1 - A case of NUT (Nuclear protein in testis) midline carcinoma of the ethmoid sinuses

AU - Matsuo, Mioko

AU - Nishijima, Toshimitsu

AU - Koike, Kouji

PY - 2017/1/1

Y1 - 2017/1/1

N2 - NUT midline carcinomas are rare epithelial malignancies. In 2016, only 48 patients with this tumor involving the head and neck were described, and ours is the second case report from Japan. These tumors are characterized by the presence of thet (15 ; 19) chromosomal translocation, difficulty in pathological diagnosis, young-onset, aggressive nature of the tumor and resistance to standard cancer therapy. We report the case of a 49 -year- old man who was diagnosed as having sinonasal NUT midline carcinoma. He had bone metastasis, and his tumor grew rapidly within a week. The initial diagnosis was Ewing sarcoma, however, the final diagnosis was NUT midline carcinoma with a t (15 ; 19) chromosomal translocation. At least once, a sarcoma-based chemotherapy regimen was effective in reducing the size of the tumor, however, the tumor regrew and became resistant to cisplatin-based chemoradiotherapy and other chemotherapies. The patient died of his disease less than 9 months after the initial diagnosis. For early diagnosis and treatment of NUT midline carcinoma, it is important to have a high index of suspicion for this disease.

AB - NUT midline carcinomas are rare epithelial malignancies. In 2016, only 48 patients with this tumor involving the head and neck were described, and ours is the second case report from Japan. These tumors are characterized by the presence of thet (15 ; 19) chromosomal translocation, difficulty in pathological diagnosis, young-onset, aggressive nature of the tumor and resistance to standard cancer therapy. We report the case of a 49 -year- old man who was diagnosed as having sinonasal NUT midline carcinoma. He had bone metastasis, and his tumor grew rapidly within a week. The initial diagnosis was Ewing sarcoma, however, the final diagnosis was NUT midline carcinoma with a t (15 ; 19) chromosomal translocation. At least once, a sarcoma-based chemotherapy regimen was effective in reducing the size of the tumor, however, the tumor regrew and became resistant to cisplatin-based chemoradiotherapy and other chemotherapies. The patient died of his disease less than 9 months after the initial diagnosis. For early diagnosis and treatment of NUT midline carcinoma, it is important to have a high index of suspicion for this disease.

UR - http://www.scopus.com/inward/record.url?scp=85038590502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038590502&partnerID=8YFLogxK

U2 - 10.3950/jibiinkoka.120.1337

DO - 10.3950/jibiinkoka.120.1337

M3 - Article

AN - SCOPUS:85038590502

VL - 120

SP - 1337

EP - 1342

JO - Journal of Otolaryngology of Japan

JF - Journal of Otolaryngology of Japan

SN - 0030-6622

IS - 11

ER -